Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapy
- Resource Type
- Article
- Authors
- Wagner, Nikolaus B.; Lenders, Max M.; Kühl, Kathrin; Reinhardt, Lydia; Fuchß, Milena; Ring, Natalie; Stäger, Ramon; Zellweger, Caroline; Ebel, Chiara; Kimeswenger, Susanne; Oellinger, Angela; Amaral, Teresa; Forschner, Andrea; Leiter, Ulrike; Klumpp, Bernhard; Hoetzenecker, Wolfram; Terheyden, Patrick; Mangana, Joanna; Loquai, Carmen; Cozzio, Antonio; Garbe, Claus; Meier, Friedegund; Eigentler, Thomas K.; Flatz, Lukas
- Source
- In European Journal of Cancer January 2024 196
- Subject
- MSC
- Language
- ISSN
- 0959-8049